CroíValve raised $36 million in Series B funding. The company develops a transcatheter valve for tricuspid regurgitation. The funding round will support clinical trials and regulatory approval efforts.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Bionyra Pharma Raises $165M in Series A Funding